Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Wezenla 130mg/26ml concentrate for inf vials
0105030B0BDAAAA
|
Wezenla | Ustekinumab | Gastro-Intestinal System | No data available |
|
Wheat grain fibrous ext 3.5g oral pdr sachets sugar free
0106010C0AAABAB
|
Bran (Wheat) | Bran | Gastro-Intestinal System | No data available |
|
Woodward's colic drops
0101010R0BGAAAG
|
Woodward's Colic | Simeticone | Gastro-Intestinal System | No data available |
|
Xenbilox 250mg capsules
0109010G0BHAAAB
|
Xenbilox | Chenodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Xermelo 250mg tablets
0104040A0BBAAAA
|
Xermelo | Telotristat ethyl | Gastro-Intestinal System | No data available |
|
Zaedoc 150 tablets
0103010T0BFAAAA
|
Zaedoc | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zanprol 10mg gastro-resistant tablets
0103050P0BEAABC
|
Zanprol | Omeprazole | Gastro-Intestinal System | No data available |
|
Zantac 150mg effervescent tablets
0103010T0BBAFAI
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 150mg/10ml syrup
0103010T0BBAEAE
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 300mg effervescent tablets
0103010T0BBAGAJ
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 50mg/2ml solution for injection ampoules
0103010T0BBADAD
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 75 Dissolve tablets
0103010T0BBAJBK
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 75 Relief Dissolve tablets
0103010T0BBAKBK
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 75 Relief tablets
0103010T0BBAIAP
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zinga 150mg capsules
0103010N0BCAAAA
|
Zinga 150 | Nizatidine | Gastro-Intestinal System | No data available |
|
Zinga 300mg capsules
0103010N0BCABAB
|
Zinga 150 | Nizatidine | Gastro-Intestinal System | No data available |
|
Zita 400mg tablets
0103010D0BIABAB
|
Zita | Cimetidine | Gastro-Intestinal System | No data available |
|
Zoton 15mg gastro-resistant capsules
0103050L0BBABAB
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zoton 30mg gastro-resistant capsules
0103050L0BBAAAA
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zoton 30mg gastro-resistant granules sachets
0103050L0BBACAD
|
Zoton | Lansoprazole | Gastro-Intestinal System | No data available |
|
Zyduco XL 1200mg tablets
0105010B0BLAAAR
|
Zyduco | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.